Factors predicting progression of IgA nephropathies

Journal of Nephrology

Volumn 18, Issue 5, 2005, Pages 503-512

  Coppo, Rosanna ^a   D'Amico, Giuseppe ^b  

^a REGINA MARGHERITA CHILDREN S HOSPITAL   (Italy)

^b SAN CARLO BORROMEO HOSPITAL   (Italy)

Author keywords

Crescents; Henoch Schoenlein purpura nephritis; IgA nephropathy; Predictive factors; Proteinuria; Renal failure progression

Indexed keywords

CREATININE;

ADHESION; AGE; ANAPHYLACTOID PURPURA; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; FOLLOW UP; GEOGRAPHIC DISTRIBUTION; GLOMERULOSCLEROSIS; GLOMERULUS; HEMATURIA; HISTOLOGY; HUMAN; HYPERTENSION; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; KIDNEY DYSFUNCTION; KIDNEY FAILURE; KIDNEY FIBROSIS; KIDNEY NECROSIS; MEAN ARTERIAL PRESSURE; MULTIVARIATE ANALYSIS; NEPHROSIS; NONBIOLOGICAL MODEL; PATIENT REFERRAL; PATIENT SELECTION; PREDICTION; PROGNOSIS; PROLIFERATIVE GLOMERULONEPHRITIS; PROTEINURIA; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; REMISSION; REVIEW; RISK ASSESSMENT; RISK FACTOR; STATISTICAL ANALYSIS; SURVIVAL RATE; VASCULITIS;

ADULT; BIOPSY; CHILD; CREATININE; GLOMERULONEPHRITIS, IGA; HUMANS; HYPERTENSION; KIDNEY; MALE; MIDDLE AGED; PROGNOSIS; PROTEINURIA; PURPURA, SCHOENLEIN-HENOCH; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 29244472451     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. D'Amico G. The commonest glomerulonephritis in the world. Q J Med 1987; 64: 707-27.
2. D'Amico G, Minetti L, Ponticelli C, Fellin G, Ferrario F, Barbiano di Belgioioso G, Imbasciati E, Ragni A, Bertoli S, Fogazzi G, Duca G. Prognostic indicators in idiopathic IgA mesangial nephropathy. Q J Med 1986; 228: 363-78.
3. Geddes CC, Rauta V, Gronhagen-Riska C, Bartosik LP, Jardine AG, Ibels LS, Pei Y, Cattran DC. A tricontinental view of IgA nephropathy. Nephrol Dial Transplant 2003; 18: 1541-8.
4. Suzuki K, Honda K, Tanabe K, Toma H, Nihei H, Yamaguchi Y. Incidence of latent mesangial IgA deposition in renal allograft donors in Japan. Kidney Int 2003; 63: 2286-94.
5. Tang Z, Wu Y, Wang QW, Yu YS, Hu WX, Yao XD, Chen HP, Liu ZH, Li LS. Idiopathic IgA nephropathy with diffuse crescent formation. Am J Nephrol 2002; 22: 480-6.
6. D'Amico G. Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Semin Nephrol 2004; 24: 179-96.
7. Bogenschutz O, Bohle A, Batz C, Wehrmann M, Pressler H, Kendziorra H, Gartner HV. IgA nephritis: on the importance of morphological and clinical parameters in the long-term prognosis of 239 patients. Am J Nephrol 1990; 10: 137-47.
8. Katafuchi R, Oh Y, Hori K, Komota T, Yanase T, Ikeda K, Omura T, Fujimi S. An important role of glomerular segmental lesions on progression of IgA nephropathy: a multivariate analysis. Clin Nephrol 1994; 41: 191-8.
9. Alamartine E, Sabatier JC, Guerin C, Berliet JM, Berthoux F. Prognostic factors in mesangial IgA glomerulonephritis: an extensive study with univariate and multivariate analyses. Am J Kidney Dis 1991; 18: 12-9.
10. Ibels LS, Gyory AZ. IgA nephropathy: analysis of the natural history, important factors in the progression of renal disease, and a review of the literature. Medicine (Baltimore) 1994; 73: 79-102.
11. Radford MG, Donadio JV, Bergstralh EJ, Grande JP. Predicting renal outcome in IgA Nephropathy. J Am Soc Nephrol 1997; 8: 199-207.
12. Bartosik LP, Lajoie G, Sugar L, Cattran DC. Predicting progression in IgA nephropathy. Am J Kidney Dis 2001; 38: 728-35.
13. D'Amico G, Ragni A, Gandini E, Fellin G. Typical and atypical natural history of IgA nephropathy in adult patients. Contrib Nephrol 1993; 104: 6-13.
14. Jafar TH, Stark PC, Schmid CH, Landa M, Maschio G, de Jong PE, de Zeeu D, Shahinfar S, Toto R, Levey AS; AIPRD Study Group. Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis. Ann Intern Med 2003; 139: 244-52.
15. Cattran DC, Greenwood C, Ritchie S. Long-term benefits of angiotensin-converting enzyme inhibitor therapy in patients with severe immunoglobulin a nephropathy: a comparison to patients receiving treatment with other antihypertensive agents and to patients receiving no therapy. Am J Kidney Dis 1994; 23: 247-54.
16. Szeto CC, Lai FM, To KF, Wong TY, Chow KM, Choi PC, Lui SF, Li PK. The natural history of immunoglobulin a nephropathy among patients with hematuria and minimal proteinuria. Am J Med 2001; 110: 434-7.
17. Usui J, Yamagata K, Kai H, Outeki T, Yamamoto S, Muro K, Hirayama A, Yoh K, Tomida C, Hirayama K, Suzuki S, Kobayashi M, Nagata M, Koyama A. Heterogeneity of prognosis in adult IgA nephropathy, especially with mild proteinuria or mild histological features. Intern Med 2001; 40: 697-702.
18. Ranieri E, Gesualdo L, Petrarulo F, Schena FP. Urinary IL6/EGF ratio: a useful prognostic marker for the progression of renal damage in IgA nephropathy. Kidney Int 1996; 50: 1990-2001.
19. D'Amico G. Clinical features and natural history in adults with IgA nephropathy. Am J Kidney Dis 1988; 12: 353-7.
20. Bennett WM, Kincaid-Smith P. Macroscopic hematuria in mesangial IgA nephropathy: correlation with glomerular crescents and renal dysfunction. Kidney Int 1983; 23: 393-400.
21. D'Amico G, Napodano P, Ferrario F, Rastaldi MP, Arrigo G. Idiopathic IgA nephropathy with segmental necrotizing lesions of the capillary wall. Kidney Int 2001; 59: 682-92.
22. Coppo R, Gianoglio B, Porcellini MG, Maringhini S for the group of Renal Immunopathology of the Italian Society of Pediatric Nephrology and group of Renal immunopathology of the Italian Society of Nephrology. Frequency of renal diseases and clinical indications for renal biopsy in children. Nephrol Dial Transplant 1998; 13: 293-7.
23. Lau KK, Gaber LW, Delos Santos NM, Fisher KA, Grimes SJ, Wyatt RJ. Pediatric IgA nephropathy: clinical features at presentation and outcome for African-Americans and Caucasians. Clin Nephrol 2004; 62: 167-72.
24. Fassbinder W, Brunner FP, Brynger H, Ehrich JH, Geerlings W, Raine AE,Rizzoni G, Selwood NH, Tufveson G, Wing AJ. Combined report on regular dialysis and transplantation in Europe, XX, 1989. Nephrol Dial Transplant 1991; 6 (Suppl 1): S5-35.
25. Hisano S, Hueda K. Asymptomatic hematuria and proteinuria: renal pathology and clinical outcome in 154 children. Pediatr Nephrol 1989; 3: 229-34.
26. Hogg RJ. Prognostic indicators and treatment of childhood IgA nephropathy. Contrib Nephrol 1995; 111: 194-200.
27. Muda AO, Feriozzi S, Rahimi S, Faraggiana T. Spatial arrangement of IgA and C3 as a prognostic indicator of IgA nephropathy. J Pathol 1995; 177: 201-8.
28. Preston GA, Waga I, Alcorta DA, Sasai H, Munger WE, Sullivan P, Phillips B, Jennette JC, Falk RJ. Gene expression profiles of circulating leukocytes correlate with renal disease activity in IgA nephropathy. Kidney Int 2004; 6: 420-30.
29. Coppo R, Basolo B, Martina G, Rollino C, De Marchi M, Giacchino F, Mazzucco G, Messina M, Piccoli G. Circulating immune complexes containing IgA, IgG and IgM in patients with primary IgA nephropathy and with Henoch-Schoenlein nephritis. Correlation with clinic and histologic signs of activity. Clin Nephrol 1982; 18: 230-9.
30. Valentijn RM, Kauffmann RH, De la Reveliere GB, Daha MR, Van Es LA. Presence of circulating macromolecular IgA in patients with hematuria due to primary IgA nepropathy. Am J Med 1983; 74: 375-81.
31. Coppo R, Basolo B, Roccatello D, Giachino O, Lajolo D, Martina G, Rollino C, Amore A, Costa M, Piccoli G. Immunological monitoring of plasma exchange in primary IgA Nephropathy. Artif Organs 1985; 9: 351-60
32. Allen AC, Harper SJ, Feehally J. Galactosylation of N- and O-linked carbohydrate moieties of IgA1 and IgG in IgA nephropathy. Clin Exp Immunol 1995; 100: 470-4.
33. Amore A, Cirina P, Conti G, Brusa P, Peruzzi L, Coppo R. Glycosylation of circulating IgA in patients with IgA Nephropathy modulates proliferation and apoptosis of mesangial cells. J Am Soc Nephrol 2001; 12: 1862-71.
34. Peruzzi L, Amore A, Cirina P, Trusolino L, Basso G, Ricotti E, Emancipator S, Marchisio PC, Coppo R. Integrin expression and IgA nephropathy: in vitro modulation by IgA with altered glycosylation and macromolecular IgA. Kidney Int 2000; 8: 2331-40.
35. Amore A, Conti G, Cirina P, Peruzzi L, Alpa M, Bussolino F, Coppo R. Aberrantly glycosylated IgA molecules downregulate the synthesis and secretion of vascular endothelial growth factor in human mesangial cells. Am J Kidney Dis 2000; 36: 1242-52.
36. Farine M, Poucell S, Geary DL, Baumal R. Prognostic significance of urinary findings and renal biopsies in children with Henoch-Schoenlein nephritis. Clin Pediatr (Phila) 1986; 25: 257-9.
37. Blanco R, Martinez-Taboada VM, Rodriguez-Valverde V, Garcia-Fuentes M, Gonzales-Gay MA. Henoch-Schoenlein purpura in adulthood and childhood: two different expressions of the same syndrome. Arthritis Rheum 1997; 40: 859-64.
38. Niaudet P, Lenoir GD, Habib R. La néphropathie du purpura rhumatoide chez l'enfant. Journée Parisienne de Pédiatrie 1986; 1: 145-50.
39. Koskimies O, Rapola J, Savilahti E, Vilska J. Renal involvement in Schoenlein-Henoch purpura. Acta Paediatr Scand 1974; 63: 357-63.
40. Goldstein AR, White RH, Akuse R, Chantler C. Long-term follow-up of childhood Henoch-Schonlein nephritis. Lancet 1992; 339: 280-2.
41. Rieu P, Noel LH. Henoch-Schoenlein nephritis in children and adults. Morphological features and clinicopathological correlations. Ann Med Interne (Paris) 1999; 150: 151-9.
42. Coppo R, Amore A. Vasculitis (ANCA negative): Henoch-Schonlein purpura. In Adu D, Emery P, Madaio M. Rheumatology and the kidney. New York: Oxford University Press 2001; 246-57.
43. Coppo R, Mazzucco G, Cagnoli L for the Italian Group of Renal Immunopathology. Long-term prognosis of Henoch-Schoenlein nephritis in adults and in children. Nephrol Dial Transplant 1997; 12: 2277-83.
44. Pillebout E, Thervet E, Hill G, Alberti C, Vanhille P, Nochy D. Henoch-Schonlein Purpura in adults: outcome and prognostic factors. J Am Soc Nephrol 2002; 13: 1271-8.
45. Saulsbury FT. Alteration in the O-linked glycosylation of IgA1 in children with Henoch Schoenlein purpura. J Rheumatol 1997; 24: 2246-9.
46. Allen AC, Willis FR, Beattie TJ, Feehally J. Abnormal IgA glycosylation in Henoch-Schonlein purpura restricted to patients with clinical nephritis. Nephrol Dial Transplant 1998; 13: 930-4.
47. Ronda N, Esnault VL, Layward L, Sepe V, Allen A, Feehally J, Lockwood CM. Antineutrophil cytoplasm antibodies (ANCA) of IgA isotype in adult Henoch-Schonlein purpura. Clin Exp Immunol 1994; 95: 49-55.
48. Coppo R, Cirina P, Amore A, Sinico RA, Radica A, Rollino C For the Italian Group of Renal Immunopathology. Properties of circulating IgA molecules in Henoch-Schonelin purpura nephritis with focus on neutrophil cytoplasmic antigen IgA binding (IgA-ANCA): New insight into a debated issue. Nephrol Dial Transplant 1997; 12: 2269-76.
49. Smith GC, Davidson JF, Hughes DA, Holme E, Beattie TJ. Complement activation in Henoch-Schoenlein purpura. Pediatr Nephrol 1997; 11: 477-80.
50. Namgoong MK, Lim B, Kim JS. Eosinophil cationic protein in Henoch-Schonlein purpura and in IgA nephropathy. Pediatr Nephrol 1997; 11: 703-6.